comparemela.com

Page 5 - Interventional Urology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript

Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript February 22, 2024 Teleflex Incorporated beats earnings expectations. Reported EPS is $3.38, expectations were $3.26. Teleflex Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome […]

Thomas powellLiam kellyGore seamguard bioabsorbablePalette life sciencesPalette life sciences onInternational urologyInterventional anesthesiaInterventional urologyNature journalProstate cancerProsthetic diseasesTitan staplerRinger catheterWhere tax filers are payingHighest percentageTheir income

Coloplast Stock: Great Quality And Growth But Priced To Perfection (OTCMKTS:CLPBY)

Coloplast Stock: Great Quality And Growth But Priced To Perfection (OTCMKTS:CLPBY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Danish stock exchangeClinical performance programmeOstomy careContinence careSkin careInterventional urologyRespiratory careColoplast investor

Teleflex dips despite Street-beating Q4

Teleflex (NYSE: TFX) shares took a hit today despite fourth-quarter results that came in ahead of the consensus forecast.

United statesMassdevice medtechLiam kellyPalette life sciencesWall streetInterventional urology

Dave Amerson and Tyler Binney Add Their Experience Commercializing Disruptive Technologies to Intrinsic Therapeutics Board of Directors

/PRNewswire/ Intrinsic Therapeutics, Inc., the developer of the Barricaid, an FDA approved medical device proven to significantly reduce reherniations and.

United statesRelievant medsystemsTyler binneyRyan drantCary haganJake tannerDave amersonBoston scientificBoard member of relievant medsystems incIntrinsic therapeutics incBoard at palette life sciencesNeotract incPresbyterian collegeCenters for diseasePrnewswire intrinsic therapeutics incUrology care foundation

Comparing Coloplast A/S (OTCMKTS:CLPBF) and Coloplast A/S (OTCMKTS:CLPBY)

Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Institutional and Insider Ownership 15.1% of Coloplast A/S […]

United kingdomUnited statesSensura mioSensura ostomyGet free reportChronic careContinence careRespiratory careInterventional urologyAdvanced wound careConveen activePeristeen plusBiatain siliconeColoplasta sOtcmkts clpbfStock comparison

vimarsana © 2020. All Rights Reserved.